Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Dupilumab
Trade Name
Synonyms REGN 668|REGN-668|REGN668|SAR 231893|SAR231893|SAR-231893
Drug Descriptions

Dupilumab is a monoclonal antibody that targets IL-4Ralpha, resulting in decreased IL-4 and IL-13 signaling and potentially leading to decreased tumor cell survival (NCI Drug Dictionary).

DrugClasses
CAS Registry Number 1190264-60-8
NCIT ID C162455

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Dupilumab + Paclitaxel + Pembrolizumab Carboplatin Dupilumab Paclitaxel Pembrolizumab 0 1
Cemiplimab + Dupilumab Cemiplimab Dupilumab 0 2
Dupilumab Dupilumab 0 1
Dupilumab + unspecified immune checkpoint inhibitor Dupilumab unspecified immune checkpoint inhibitor 0 0
Dupilumab + unspecified PD-1 antibody Dupilumab unspecified PD-1 antibody 0 1
Dupilumab + unspecified PD-L1 antibody Dupilumab unspecified PD-L1 antibody 0 1


Additional content available in CKB BOOST